18. 脊髄小脳変性症（多系統萎縮症を除く。） Spinocerebellar degeneration Clinical trials / Disease details

臨床試験数 : 71 / 薬物数 : 99 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02705547 (ClinicalTrials.gov)	May 2016	5/3/2016	Rosuvastatin (Crestor) in Friedreich Ataxia	Open-label Biomarker Study of Rosuvastatin(Crestor) for the Treatment of Patients With Friedreich At ...	Friedreich Ataxia	Drug: Rosuvastatin	Children's Hospital of Philadelphia	Friedreich's Ataxia Research Alliance	Completed	18 Years	65 Years	All	12	Early Phase 1	United States